abstract |
(57) [Summary] (Wherein each symbol is as defined in the specification), or a pharmaceutically acceptable salt thereof, a method for producing them, a pharmaceutical composition containing them, and a human thereof. Or, for use in treating tachykinin-mediated diseases in animals. |